Study Summary
This trial will test how an intervention program affects different regions of the brain in order to better prevent or reduce risky behaviors among African-American youth, who are highly vulnerable to the consequences of such behavior.
- Adolescent Behaviors
- Risk-Taking
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: 3 months post-intervention
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Wait-list
1 of 2
Pathways for African-Americans' Success
1 of 2
Active Control
Experimental Treatment
128 Total Participants · 2 Treatment Groups
Primary Treatment: Pathways for African-Americans' Success (PAAS) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age < 18 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 28th, 2021
Last Reviewed: November 30th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.